What are the electrophysiological mechanisms underlying premature ventricular contractions (PVCs) in a non‑ischemic heart?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Electrophysiology of PVCs in Non-Ischemic Hearts

In non-ischemic hearts, PVCs arise primarily through three electrophysiological mechanisms: enhanced or abnormal automaticity in the His-Purkinje system or ventricular myocardium, triggered activity from delayed afterdepolarizations (most common in structurally normal hearts), and reentry around areas of patchy fibrosis in cardiomyopathic substrates 1, 2.

Core Mechanisms

Automaticity

  • Normal automaticity occurs when subordinate pacemaker cells in the His-Purkinje system exhibit enhanced phase 4 spontaneous depolarization, reaching threshold prematurely and firing before the next sinus beat 1, 2
  • The rate depends on three factors: maximum diastolic potential, slope of phase 4 depolarization, and threshold potential
  • Abnormal automaticity arises from partially depolarized membrane potentials (closer to calcium channel activation potential), though this is less common in non-ischemic hearts since it typically requires injury currents from ischemia 1
  • Enhanced automaticity can result from increased intracellular calcium content or heightened sensitivity of pacemaker cells 2

Triggered Activity

  • Delayed afterdepolarizations are the predominant triggered activity mechanism in non-ischemic hearts 3
  • These result from spontaneous calcium release from the sarcoplasmic reticulum, activating a depolarizing sodium-calcium exchange current 2
  • Abnormal calcium handling appears crucial—animal models demonstrate this as a key mechanism underlying PVC-induced cardiomyopathy 4
  • Early afterdepolarizations (occurring during phase 2-3 of the action potential) are less relevant in structurally normal hearts, being more associated with QT prolongation syndromes 2, 5

Reentry in Non-Ischemic Substrates

  • While reentry is the dominant mechanism in ischemic heart disease, it also occurs in non-ischemic cardiomyopathy around patchy fibrosis 1, 2
  • The substrate includes areas of myocardial fibrosis and left ventricular hypertrophy—increasingly recognized as important SCD substrates 2
  • Both anatomical reentry (around fixed obstacles) and functional reentry (around areas of functional block) can occur 2

Critical Role of Tissue Heterogeneity

A novel concept is the "gerrymandering" effect: structural and functional tissue heterogeneities can electrically isolate small clusters of pathological cells 6. This overcomes the normal "source-sink mismatch" where healthy surrounding myocardium suppresses abnormal signals. Regions of weak electrical coupling or specific cellular arrangements allow abnormal cell clusters to reach the critical mass needed to initiate PVCs 6.

Dynamic Modulation

The electrophysiological substrate is dynamically influenced by 1, 2:

  • Cardiac metabolism
  • Electrolyte disturbances
  • Signaling pathways
  • Autonomic nervous system effects
  • Ion channel or transporter function changes
  • Cell-to-cell coupling alterations

Clinical Pitfalls

Common misconception: Assuming all PVCs in non-ischemic hearts are benign. While the substrate differs from ischemic disease, patchy fibrosis in cardiomyopathy creates reentrant circuits that can sustain ventricular tachycardia and increase SCD risk 2.

Key distinction: The non-ischemic substrate lacks the acute injury currents and ischemia-related abnormal automaticity seen in coronary disease, making triggered activity and enhanced normal automaticity relatively more important mechanisms 1, 3.

Risk factors for progression: QRS duration of the PVC, coupling interval, and male sex predict development of PVC-induced cardiomyopathy, with abnormal calcium handling as the underlying mechanism 4. Shorter coupling intervals prolong QRS duration and worsen hemodynamics, particularly when PVCs originate from the left ventricle 7.

Related Questions

Can premature ventricular contractions (PVCs) be related to recent changes such as milrinone therapy, electrolyte abnormalities, or myocardial injury?
Can an otherwise asymptomatic adult woman with 14 premature ventricular complexes (PVCs) per minute safely undergo a major operation such as a hysterectomy?
In a patient with a 17% premature ventricular contraction (PVC) burden on Holter monitoring and a normal coronary angiogram, what is the next step in management?
Can a premature ventricular contraction (PVC) be a perfusing beat?
What is the recommended management for ventricular ectopic beats (premature ventricular contractions)?
Can I switch from sertraline (100 mg) to escitalopram (10 mg) to avoid mental fog?
In a patient with Addison's disease, serum sodium 129 mmol/L, normal potassium, currently treated with hydrocortisone 20 mg in the morning and 10 mg in the afternoon and fludrocortisone half tablet daily, what is the appropriate next step in management?
Should a 1‑year‑11‑month‑old child with a history of febrile seizures who is coinfected with COVID‑19 and influenza B be referred to the hospital for evaluation and management?
What postoperative pulmonary complications are expected in a patient with severe chronic obstructive pulmonary disease (forced expiratory volume in one second (FEV1) ~48% predicted, forced expiratory flow at 25‑75% (FEF 25‑75) ~16% predicted) after coronary artery bypass grafting?
Until which week of gestation should low‑dose aspirin be continued in a pregnant patient with systemic lupus erythematosus and a positive lupus anticoagulant?
Should loperamide be given to a severely dehydrated patient while stool analysis and stool culture are pending?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.